Myelodysplastic Syndromes Fund

Myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells. Patients who have myelodysplastic syndromes have immature blood stem cells that don’t mature over time, as they should. These non-functional immature cells begin to take up space in the blood, leaving fewer healthy blood cells. As many as 30,000 new cases are diagnosed each year. It’s uncommon before age 50, and the risk increases as a person ages. Approximately 170,000 people currently suffer with MDS in the US.